Week4, 2024
1. Influenza activity remains elevated nationwide, with 16.2% of respiratory specimens testing positive for influenza in clinical labs this week.
2. Among public health labs, 78.9% of detected influenza viruses were Influenza A, of which 60.4% were A(H1N1)pdm09 and 39.6% were A(H3N2). Influenza B accounted for 21.1%.
3. Outpatient visits for respiratory illness accounted for 4.3% of visits, above the national baseline for the 13th consecutive week, with moderate to very high activity reported in 33 jurisdictions.
4. The cumulative hospitalization rate is 47.8 per 100,000, highest among adults aged 65+ (128.6 per 100,000), with 88.3% of hospitalizations due to Influenza A.
5. Mortality attributed to influenza decreased to 0.9% this week, while eight new pediatric deaths bring the seasonâ€™s total to 65.
6. CDC estimates approximately 20 million illnesses, 230,000 hospitalizations, and 14,000 deaths from flu so far this season.
7. Vaccination rates and antiviral medications are emphasized as critical preventive measures; vaccination is encouraged for everyone aged 6 months and older.
8. Respiratory viruses like COVID-19 and RSV are co-circulating, with 4.0% of flu-associated hospitalizations testing positive for SARS-CoV-2.
9. Regional trends show varying increases and decreases in influenza positivity and respiratory illness, with notable increases in regions 6 and 8.
10. Evolutionary changes in influenza viruses are monitored, and high levels of resistance to adamantanes persist, but susceptibility to neuraminidase inhibitors remains high.